Brokerages Set Bioceres Crop Solutions Corp. (NASDAQ:BIOX) PT at $4.00

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has been assigned a consensus rating of “Hold” from the four ratings firms that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating on the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $4.00.

Several equities research analysts have weighed in on the stock. Weiss Ratings upgraded shares of Bioceres Crop Solutions from a “sell (d-)” rating to a “sell (d)” rating in a research note on Friday, June 26th. Wall Street Zen lowered Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a report on Saturday, April 4th.

Bioceres Crop Solutions Stock Up 2.3%

BIOX traded up $0.01 on Friday, hitting $0.34. The company had a trading volume of 52,961 shares, compared to its average volume of 222,879. The stock has a market capitalization of $21.70 million, a price-to-earnings ratio of -0.09 and a beta of 0.42. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.70 and a current ratio of 0.88. The stock has a fifty day moving average price of $0.41 and a 200-day moving average price of $0.65. Bioceres Crop Solutions has a 12-month low of $0.31 and a 12-month high of $4.40.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings results on Monday, May 11th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.11). The firm had revenue of $39.40 million during the quarter, compared to the consensus estimate of $54.50 million. Bioceres Crop Solutions had a negative net margin of 92.85% and a negative return on equity of 33.97%. Analysts predict that Bioceres Crop Solutions will post -0.16 EPS for the current fiscal year.

Institutional Investors Weigh In On Bioceres Crop Solutions

Institutional investors have recently added to or reduced their stakes in the business. Jones Financial Companies Lllp lifted its stake in shares of Bioceres Crop Solutions by 3,535.8% during the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock worth $25,000 after buying an additional 5,339 shares during the period. Bank of America Corp DE increased its position in shares of Bioceres Crop Solutions by 186.7% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after acquiring an additional 3,735 shares during the period. Virtu Financial LLC acquired a new position in shares of Bioceres Crop Solutions in the 3rd quarter valued at $40,000. Invesco Ltd. purchased a new position in Bioceres Crop Solutions in the 4th quarter worth $45,000. Finally, PDT Partners LLC raised its stake in Bioceres Crop Solutions by 58.9% in the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock worth $126,000 after acquiring an additional 10,449 shares during the last quarter. Institutional investors and hedge funds own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.